Literature DB >> 28373038

Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan.

Chun-Ming Lee1, Chih-Cheng Lai2, Hsiu-Tzy Chiang3, Min-Chi Lu4, Ling-Fang Wang5, Tsai-Ling Tsai6, Mei-Yu Kang7, Yi-Ni Jan8, Yi-Ting Lo9, Wen-Chien Ko10, Shu-Hui Tseng11, Po-Ren Hsueh12.   

Abstract

OBJECTIVES: This study investigated the prevalence of multidrug-resistant organisms (MDROs) in the residents and environments of long-term care facilities (LTCFs) in Taiwan.
METHODS: We prospectively investigated the distribution of MDROs in residents of six LTCFs and their environments from January 2015 to December 2015 (intervention period). Active surveillance of colonization of MDROs was performed by culturing rectal and nasal swab samples every 3 months for the residents: 63, 79, and 73 in the first, second, and third surveillance investigations, respectively. If MDROs, including methicillin-resistant Staphylococcus aureus, carbapenem-resistant Enterobacteriaceae, carbapenem-resistant Pseudomonas aeruginosa, and MDR Acinetobacter baumannii were identified, then swab specimens from environmental sources were also collected and cultured. During the study period, several infection control measures were also implemented.
RESULTS: The overall infection density decreased significantly from 2.69 per 1000 patient-days in the preintervention (January 2014 to December 2014) to 2.39 per 1000 patient-days during the intervention period (p < 0.001). A total of 154 samples from residents and environmental sources were positive for MDROs. Methicillin-resistant S. aureus (n = 83, 53.9%) was the predominant organism, followed by carbapenem-resistant Enterobacteriaceae (n = 35, 22.7%), MDR A. baumannii (n = 30, 19.5%), and carbapenem-resistant P. aeruginosa (n = 6, 3.9%). The rates of detection of MDROs were 27.9% (60/215) in nasal swabs, 15.8% (34/215) in rectal swabs, and 11.1% (60/542) in the environmental sources.
CONCLUSIONS: The distribution and persistence of MDROs varied among the different LTCFs and time periods.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  environment; infection control; long-term care facility; multidrug-resistant organisms; residents

Mesh:

Year:  2017        PMID: 28373038     DOI: 10.1016/j.jmii.2016.12.001

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  16 in total

1.  Mortality in Thai Nursing Homes Based on Antimicrobial-Resistant Enterobacterales Carriage and COVID-19 Lockdown Timing: A Prospective Cohort Study.

Authors:  Thundon Ngamprasertchai; Muthita Vanaporn; Sant Muangnoicharoen; Wirichada Pan-Ngum; Narisa Ruenroengbun; Pittaya Piroonamornpun; Thitiya Ponam; Chatnapa Duangdee; Phanita Chankete; Anupop Jitmuang; Visanu Thamlikitkul
Journal:  Antibiotics (Basel)       Date:  2022-06-02

2.  Colonization With Multidrug-Resistant Organisms Among Healthy Adults in the Community Setting: Prevalence, Risk Factors, and Composition of Gut Microbiome.

Authors:  Yu-Shan Huang; Liang-Chuan Lai; Yu-An Chen; Kuan-Yin Lin; Yi-Hsuan Chou; Hsiu-Chi Chen; Shu-Sheng Wang; Jann-Tay Wang; Shan-Chwen Chang
Journal:  Front Microbiol       Date:  2020-06-24       Impact factor: 5.640

Review 3.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

4.  In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

Authors:  Shio-Shin Jean; Min-Chi Lu; Zhi-Yuan Shi; Shu-Hui Tseng; Ting-Shu Wu; Po-Liang Lu; Pei-Lan Shao; Wen-Chien Ko; Fu-Der Wang; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2018-10-26       Impact factor: 4.003

Review 5.  Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects.

Authors:  Shio-Shin Jean; Nan-Yao Lee; Hung-Jen Tang; Min-Chi Lu; Wen-Chien Ko; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

6.  Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

Authors:  Chih-Cheng Lai; Ying-Sheng Chen; Nan-Yao Lee; Hung-Jen Tang; Susan Shin-Jung Lee; Chin-Fu Lin; Po-Liang Lu; Jiunn-Jong Wu; Wen-Chien Ko; Wen-Sen Lee; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2019-03-14       Impact factor: 4.003

7.  Diversity of nasal microbiota and its interaction with surface microbiota among residents in healthcare institutes.

Authors:  Chang-Hua Chen; Ming-Li Liou; Cheng-Yang Lee; Ming-Chuan Chang; Han-Yueh Kuo; Tzu-Hao Chang
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

8.  Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016.

Authors:  Chun-Hsing Liao; Na-Yao Lee; Hung-Jen Tang; Susan Shin-Jung Lee; Chin-Fu Lin; Po-Liang Lu; Jiunn-Jong Wu; Wen-Chien Ko; Wen-Sen Lee; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2019-03-04       Impact factor: 4.003

9.  Rapid Determination of Antibiotic Resistance in Klebsiella pneumoniae by a Novel Antibiotic Susceptibility Testing Method Using SYBR Green I and Propidium Iodide Double Staining.

Authors:  Yabin Zhang; Weihua Fan; Chunhong Shao; Jiajia Wang; Yan Jin; Jing Shao; Ying Zhang; Yong Wang
Journal:  Front Microbiol       Date:  2021-06-09       Impact factor: 5.640

10.  The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA.

Authors:  Chih-Cheng Lai; Chi-Chung Chen; Ying-Chen Lu; Yin-Ching Chuang; Hung-Jen Tang
Journal:  Infect Drug Resist       Date:  2018-05-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.